A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma (NIBIT-M1)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Italian Network for Tumor Biotherapy
ClinicalTrials.gov Identifier:
NCT01654692
First received: July 18, 2012
Last updated: July 28, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2013
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
No publications provided by Italian Network for Tumor Biotherapy

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):